Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Tumor Profiling Market Be Worth By 2029?

There has been a swift expansion in the tumor profiling market size in the past few years. The market is projected to escalate from $10.16 billion in 2024 to $11.18 billion in 2025, marking a compound annual growth rate (CAGR) of 10.0%. Factors contributing to the growth in this historical period include escalating frequency of cancer cases, amplified demand for custom-made medicine, growth in health expenditure, an increase in embracing companion diagnostics, and elevated awareness about early detection of cancer.

The market for tumor profiling is projected to experience significant expansion in the upcoming years, reaching approximately $16.37 billion by 2029 with a compound annual growth rate (CAGR) of 10.0%. This expected increase during the forecast period can be ascribed to the escalating use of liquid biopsy procedures, an increase in funding for cancer-based research and development, a rising elderly population, enhanced application of targeted treatments, and an upsurge in collaborative efforts for cancer research. Future trends to look out for in this period include a shift towards companion diagnostics, an increase in multi-gene tests, advancements in next-generation sequencing technology, incorporation of artificial intelligence (AI) in cancer detection, and progress in tumor profiling methods.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

Which Key Factors Are Fueling Growth In The Tumor Profiling Market?

The burgeoning requirements for tailored healthcare, also known as personalized medicine, are predicted to fuel the expansion of the tumor profiling market. Personalized medicine crafts health treatments according to each patient’s unique attributes. The rising trend is attributed to patients preferring therapies that assure improved results and lesser side effects in comparison to conventional treatments. Tumor profiling plays a key role in enhancing personalized medicine due its ability to identify individual genetic changes and biomarkers in a patient’s tumor, leading to aimed therapies and reduction in side effects. For instance, in February 2024, the Personalized Medicine Coalition, a dedicated US-based organization promoting personalized medicine, published a report stating that personalized medicines represented more than one-third of all new medicine approvals in 2023. This was the fourth consecutive year of such a trend, proving the increasing demand for personalized medicine is fuelling the tumor profiling market’s growth.

Which Segmentation Factors Are Critical In The Tumor Profiling Market Analysis?

The tumor profilingmarket covered in this report is segmented –

1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics

2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray

3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research

Subsegments:

1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing

2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting

3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis

4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)

How Are Global Trends Impacting The Development Of The Tumor Profiling Market?

In the tumor profiling market, key players are concentrating on creating cutting-edge solutions, like artificial intelligence (AI)-aided diagnostic tools, to boost precision and effectiveness in cancer care. AI indicates the application of sophisticated computational techniques to interpret intricate genomic, proteomic, and clinical information, expediting diagnoses, tailoring treatment plans, and improving disease tracking. In a notable development in January 2025, UK-based Panakeia Technologies LTD, known for its AI software for cancer diagnosis and therapy, unveiled PANProfiler Colon. This AI software solution was expressly created to analyze crucial molecular markers such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR)—from H and E-stained images of colon cancer tissue specimens. This digital asset provides quick and precise molecular profiling of tumors, which is crucial for diagnosing colorectal cancer, spotting Lynch syndrome cases and guiding individualized treatment choices.

Which Players Are Shaping The Competitive Landscape Of The Tumor Profiling Market?

Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Tumor Profiling Market?

North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

Browse Through More Reports Similar to the Global Tumor Profiling Market 2025, By The Business Research Company

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Brain Tumor Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model